Lv5
1110 积分 2025-03-22 加入
Immune-mediated side effects of cancer immunotherapies
1天前
已完结
Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
1天前
已完结
Allogeneic B7-H3-targeted CAR-Vδ1T cell therapy in advanced solid tumors: A phase I study
1天前
已完结
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
1天前
已完结
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
11天前
已完结
Heterogeneous responses of IM19 anti-CD19 CAR T-cell therapy in refractory systemic lupus erythematosus: an open-label pilot study and a mini-review
13天前
已完结
Precision immunotherapies for systemic lupus erythematosus: From pathogenic targets to translational horizons
17天前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
21天前
已完结
Ultra-sensitive CAR T cells eliminate hard-to-treat tumours in mice
22天前
已关闭
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
22天前
已完结
皖公网安备34019202002308
